Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 55779-18-5 | MDL No. : | MFCD00867210 |
Formula : | C12H9ClFN5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NAPNOSFRRMHNBJ-UHFFFAOYSA-N |
M.W : | 277.68 | Pubchem ID : | 41574 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 15 |
Fraction Csp3 : | 0.08 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 70.44 |
TPSA : | 69.62 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.27 cm/s |
Log Po/w (iLOGP) : | 2.02 |
Log Po/w (XLOGP3) : | 2.43 |
Log Po/w (WLOGP) : | 2.68 |
Log Po/w (MLOGP) : | 2.14 |
Log Po/w (SILICOS-IT) : | 2.07 |
Consensus Log Po/w : | 2.27 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.54 |
Solubility : | 0.0792 mg/ml ; 0.000285 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.53 |
Solubility : | 0.081 mg/ml ; 0.000292 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.8 |
Solubility : | 0.00443 mg/ml ; 0.000016 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.09 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1335299-39-2 ]
2-(4-Fluorophenyl)imidazo[1,2-a]pyrimidin-7-amine
Similarity: 0.57
[ 428854-24-4 ]
2-(1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6-triamine
Similarity: 0.57
[ 1639417-53-0 ]
(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one
Similarity: 0.56
[ 162012-67-1 ]
N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Similarity: 0.56
[ 33400-49-6 ]
N2-(4-Fluorobenzyl)-5-nitropyridine-2,6-diamine
Similarity: 0.55
[ 39639-47-9 ]
N-Benzyl-2-chloro-9H-purin-6-amine
Similarity: 0.63
[ 79064-26-9 ]
9-Benzyl-2,6-dichloro-9H-purine
Similarity: 0.62
[ 1334411-79-8 ]
4-Bromo-2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridine
Similarity: 0.58
[ 1335299-39-2 ]
2-(4-Fluorophenyl)imidazo[1,2-a]pyrimidin-7-amine
Similarity: 0.57
[ 39639-47-9 ]
N-Benzyl-2-chloro-9H-purin-6-amine
Similarity: 0.63
[ 79064-26-9 ]
9-Benzyl-2,6-dichloro-9H-purine
Similarity: 0.62
[ 7013-21-0 ]
2-Chloro-9-methyl-9H-purin-6-amine
Similarity: 0.59
[ 1334411-79-8 ]
4-Bromo-2-(2,6-dichlorophenyl)-1H-imidazo[4,5-c]pyridine
Similarity: 0.58
[ 39861-21-7 ]
4-(5-Chloro-1H-benzo[d]imidazol-2-yl)aniline
Similarity: 0.56
[ 39639-47-9 ]
N-Benzyl-2-chloro-9H-purin-6-amine
Similarity: 0.63
[ 14047-28-0 ]
(R)-1-(6-Amino-9H-purin-9-yl)propan-2-ol
Similarity: 0.61
[ 7013-21-0 ]
2-Chloro-9-methyl-9H-purin-6-amine
Similarity: 0.59
[ 39639-47-9 ]
N-Benzyl-2-chloro-9H-purin-6-amine
Similarity: 0.63
[ 79064-26-9 ]
9-Benzyl-2,6-dichloro-9H-purine
Similarity: 0.62
[ 14047-28-0 ]
(R)-1-(6-Amino-9H-purin-9-yl)propan-2-ol
Similarity: 0.61
[ 7013-21-0 ]
2-Chloro-9-methyl-9H-purin-6-amine
Similarity: 0.59